Verified Nov 2026
Batteries & E-Mobility
·
Berlin, Berlin
·
Since 1997
Eckert & Ziegler SE is a German isotope technology company headquartered in Berlin and founded in 1997. It employs between 1,000 and 5,000 people and is publicly listed under the ticker EUZ.DE. The company serves the medical, industrial, scientific and renewable-energy sectors, with products for nuclear medicine and radiotherapy. Its recent developments include receiving a GMP certificate for Actinium-225 production on 28 October 2026, and a February 2026 agreement with Molecular Partners to develop targeted alpha radiotherapeutics.
Eckert & Ziegler SE at a glance
Revenue
365.7M
Employees
1,000-5,000
Founded
1997
Headquarters
Berlin, Berlin
Ownership
Publicly traded (ETRA: EUZ.DE)
Certifications
ISO 9001
Industries
Automotive
Electric Vehicles
Medical
Renewable Energy
Industrial Equipment
STABILITY SIGNALS
Established & strong
29 years in operation (founded 1997).
Publicly listed; no distress event on record.
Holds ISO 9001 certification(s) per public sources.
Overview
Eckert & Ziegler SE is a German isotope technology company headquartered in Berlin and founded in 1997. It employs between 1,000 and 5,000 people and is publicly listed under the ticker EUZ.DE. The company serves the medical, industrial, scientific and renewable-energy sectors, with products for nuclear medicine and radiotherapy. Its recent developments include receiving a GMP certificate for Actinium-225 production on 28 October 2026, and a February 2026 agreement with Molecular Partners to develop targeted alpha radiotherapeutics.
At a glance
Attribute | Detail |
|---|---|
Founded | 1997 |
Headquarters | Berlin, Berlin |
Employees | 1,000-5,000 |
Revenue | 365.7M |
Ownership | Publicly traded (ETRA: EUZ.DE) |
Primary capability | Batteries & E-Mobility |
Certifications | ISO 9001 |
What Eckert & Ziegler SE makes
The company holds ISO 9001 certification and produces isotope sources, brachytherapy products and radiopharmaceuticals, including the products Yttriga and GalliaPharm.
Products and capabilities described on the company's own site include Steel, Bearing (source: ezag.com).
Certifications
Eckert & Ziegler SE is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:
ISO 9001 — ezag.com
Latest developments
2026-10-28 — Eckert & Ziegler Receives GMP Certificate for Actinium-225 | Eckert & Ziegler Medical (ezag.com)
2026-09-10 — Ru-106 Eye Applicators – awarded to Eckert & Ziegler BEBIG Ltd. (tenderroster.com)
2026-02-26 — Molecular Partners Signs Development Agreement with Eckert & Ziegler for Targeted Alpha Radiotherapeutics | Molecular Partners (molecularpartners.com)
2026-02-16 — Eckert & Ziegler and UJF Significantly Increase Production Volume for Actinium-225 | Corporate - EQS News (eqs-news.com)
2025-04-24 — Pentixapharm Signs Contract Manufacturing Agreement for Yttrium-90-based PentixaTher with Eckert & Ziegler SE — Pentixapharm (pentixapharm.com)
2025-03-20 — Eckert & Ziegler and AtomVie Global Radiopharma Sign a Global Agreement for Lutetium-177 Supply (prnewswire.com)
Company details
The company is publicly traded and reports revenue of about 365.7 million, with a February 2026 development agreement with Molecular Partners and a 2025 contract manufacturing agreement with Pentixapharm for yttrium-90-based PentixaTher. Eckert & Ziegler SE was founded in 1997, has an estimated 1,000-5,000 employees, and is headquartered in Berlin, Berlin. On the LightSource stability read it is rated "Established & strong": 29 years in operation (founded 1997). Publicly listed; no distress event on record. Holds ISO 9001 certification(s) per public sources.
Frequently asked questions
What does Eckert & Ziegler SE make?
Eckert & Ziegler SE is a German isotope technology company headquartered in Berlin and founded in 1997. It employs between 1,000 and 5,000 people and is publicly listed under the ticker EUZ.DE. The company serves the medical, industrial, scientific and renewable-energy sectors, with products for nuclear medicine and radiotherapy. Its recent developments include receiving a GMP certificate for Actinium-225 production on 28 October 2026, and a February 2026 agreement with Molecular Partners to develop targeted alpha radiotherapeutics.
Where is Eckert & Ziegler SE headquartered?
Eckert & Ziegler SE is headquartered in Berlin, Berlin (10 Robert-Roessle-Strasse, Berlin, Berlin, 13125).
When was Eckert & Ziegler SE founded?
Eckert & Ziegler SE was founded in 1997.
How big is Eckert & Ziegler SE?
Eckert & Ziegler SE has an estimated 1,000-5,000 employees, with revenue in the 365.7M range.
Is Eckert & Ziegler SE publicly traded?
Publicly traded (ETRA: EUZ.DE). Public financial figures are drawn from its filings.
What certifications does Eckert & Ziegler SE hold?
Eckert & Ziegler SE lists ISO 9001 on its website. Confirm the certified scope for the specific plant producing your part.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile comes from a public-data sample of around 1,000 companies. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.